Advancements in ROS1+ NSCLC Treatment Offer New Hope
Recent advancements in the treatment of ROS1-positive non-small cell lung cancer (NSCLC) have significantly improved patient outcomes, offering a wider array of therapeutic options. Dr. Jorge J. Nieva, an associate…